Key Points
- Dominari CEO Anthony Hayes purchased 50,000 shares at an average price of $2.02, investing $101,000 and increasing his direct ownership to 4.55 million shares.
- Dominari shares opened at $2.23, with a market capitalization of approximately $54.1 million; the stock remains well below its 52-week high of $8.40.
- The company beat quarterly EPS expectations, reporting a loss of $0.21 per share versus the estimated loss of $0.34, but analysts maintain an overall “Sell” rating amid continued net losses and negative returns.
Dominari Holdings Inc. (NASDAQ:DOMH - Get Free Report) CEO Anthony Hayes acquired 50,000 shares of the stock in a transaction on Thursday, September 10th. The stock was purchased at an average cost of $2.02 per share, with a total value of $101,000.00. Following the transaction, the chief executive officer directly owned 4,550,873 shares of the company's stock, valued at $9,192,763.46. This represents a 1.11% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.
Dominari Stock Up 2.3%
DOMH opened at $2.23 on Tuesday. The firm's 50 day moving average is $2.55 and its 200-day moving average is $2.92. Dominari Holdings Inc. has a 52-week low of $1.91 and a 52-week high of $8.40. The firm has a market capitalization of $54.06 million, a P/E ratio of -0.41 and a beta of 0.87.
Dominari (NASDAQ:DOMH - Get Free Report) last released its quarterly earnings results on Monday, August 10th. The company reported ($0.21) earnings per share for the quarter, beating analysts' consensus estimates of ($0.34) by $0.13. Dominari had a negative net margin of 51.61% and a negative return on equity of 235.37%. The business had revenue of $16.79 million during the quarter, compared to analyst estimates of $16.79 million.
Analyst Ratings Changes
A number of analysts have recently issued reports on the company. Wall Street Zen lowered Dominari from a "hold" rating to a "sell" rating in a research report on Saturday, August 15th. Weiss Ratings reissued a "sell (d-)" rating on shares of Dominari in a report on Monday, July 6th. One analyst has rated the stock with a Sell rating, According to MarketBeat, Dominari currently has an average rating of "Sell".
Read Our Latest Research Report on DOMH
Institutional Trading of Dominari
Several institutional investors have recently added to or reduced their stakes in DOMH. Creek Drive Management Group LLC bought a new position in Dominari during the 4th quarter valued at $1,861,000. Connective Capital Management LLC grew its holdings in Dominari by 112.9% during the 2nd quarter. Connective Capital Management LLC now owns 243,223 shares of the company's stock worth $764,000 after acquiring an additional 128,994 shares in the last quarter. Renaissance Technologies LLC increased its position in shares of Dominari by 59.1% in the 1st quarter. Renaissance Technologies LLC now owns 132,362 shares of the company's stock worth $430,000 after purchasing an additional 49,162 shares during the last quarter. Finally, PFG Investments LLC raised its stake in shares of Dominari by 36.3% in the 1st quarter. PFG Investments LLC now owns 14,475 shares of the company's stock valued at $47,000 after purchasing an additional 3,855 shares in the last quarter. 42.48% of the stock is owned by institutional investors and hedge funds.
Dominari Company Profile
(
Get Free Report)
Dominari Holdings Inc, a biotechnology company, focuses on developing small-molecule anticancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
